Sponsored Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community January 23, 2026Vol.52 No.03By Tanya Dorff
Sponsored Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology January 09, 2026Vol.52 No.1By Ofer Sharon, Michal Harel and Yehonatan Elon
Sponsored Mitochondrial-targeting drug attacks cancer cells from within December 19, 2025Vol.51 No.46By Hayley Kamin
Sponsored Fixing site reads without burning out the readersYunu modernizes clinical trial imaging assessment workflows December 05, 2025Vol.51 No.44By Jeff Sorenson
Sponsored Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration November 21, 2025Vol.51 No.43By The American Society of Clinical Oncology
Sponsored Advancing symptom science at City of Hope and across the globe November 14, 2025Vol.51 No.42By Jeannine M. Brant
Sponsored City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure November 07, 2025Vol.51 No.41By Ravi Salgia
Sponsored Why both somatic and germline genomic profiling are essential for precision oncology October 17, 2025Vol.51 No.38By Heather Hampel and David W. Craig
Sponsored The evolution of cellular immunotherapy: From transplant to CAR T cells October 03, 2025Vol.51 No.36By Stephen J. Forman
Sponsored Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence September 26, 2025Vol.51 No.35By Stephen D. Nimer
